Financial insights of XBIO

MyFinsight

For the quarter ending 2026-03-31, XBIO made $806,923 in revenue. -$456,382 in net income. Net profit margin of -56.56%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenue	806,923	766,296	1,026,957	589,897
Research and development	661,443	773,416	756,482	656,557
General and administrative	647,597	615,907	815,209	657,752
Total operating costs and expenses	1,309,040	1,389,323	1,571,691	1,314,309
Loss from operations	-502,117	-623,027	-544,734	-724,412
Other (expense) income	-21	159	4,011	1,477
Interest income, net	45,756	43,792	30,783	34,232
Total other income, net	45,735	43,951	34,794	35,709
Net loss	-456,382	-579,076	-509,940	-688,703

Basic EPS	-0.2	-0.266	-0.33	-0.45
Diluted EPS	-0.2	-0.266	-0.33	-0.45
Basic Average Shares	2,291,056	2,179,867	1,542,139	1,542,139
Diluted Average Shares	2,291,056	2,179,867	1,542,139	1,542,139

Unit: Dollar. Numbers labeled with * are estimated quarterly values.